Facit | Cancer Breakthroughs Realized
Facit | Cancer Breakthroughs Realized
  • About
    • About FACIT
    • Our Network
    • Leadership
    • Careers
    • Contact
  • Portfolio
  • Funds
    • Funds & Programs Overview
      • Prospects
      • Compass Rose
      • WeSEED
  • Falcons’ Fortunes
    • Event Info & RSVP
    • Pitch Competition – apply
  • News
Normal High
Text Size:

Portfolio Category: Prospects

FACIT-52 | Bridge7 Oncology

October 5, 2021 –

Read More from FACIT-52 | Bridge7 Oncology

FACIT-53 | Replica Analytics (acquired by Aetion)

October 5, 2021 –

Read More from FACIT-53 | Replica Analytics (acquired by Aetion)

FACIT-36 | DNAstack

October 5, 2021 –

Read More from FACIT-36 | DNAstack

FACIT-54 | Multimagnetics Inc.

October 5, 2021 –

Read More from FACIT-54 | Multimagnetics Inc.

FACIT-37 | Dalriada Therapeutics

October 5, 2021 –

Read More from FACIT-37 | Dalriada Therapeutics

FACIT-55 | University of Toronto (mitochondrial RNA polymerase inhibitor, Dr. R. Laposa)

October 5, 2021 –

Read More from FACIT-55 | University of Toronto (mitochondrial RNA polymerase inhibitor, Dr. R. Laposa)

FACIT-38 | KA Imaging

October 5, 2021 –

Read More from FACIT-38 | KA Imaging

FACIT-57 | Air Microfluidic Systems Inc.

October 5, 2021 –

Read More from FACIT-57 | Air Microfluidic Systems Inc.

FACIT-39 | Radialis Medical

October 5, 2021 –

Read More from FACIT-39 | Radialis Medical

FACIT-58 | Tenomix

October 5, 2021 –

Read More from FACIT-58 | Tenomix

Posts navigation

  • «
  • 1
  • 2
  • 3
  • 4
  • 5
  • »
  • Privacy Policy
  • Accessibility
  • Terms & Conditions
  • Reporting Improper Activities

FACIT
MaRS Centre
661 University Ave., Suite 510
Toronto, Ontario, Canada M5G 0A3

E: info (at) facit.ca